Lista de obras - Vincenzo Russo - Dominio Público Uruguay

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

artículo científico publicado en 2011

A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes

artículo científico publicado en 2002

A dual role for genetically modified lymphocytes in cancer immunotherapy.

artículo científico publicado en 2012

A family of rapidly evolving genes from the sex reversal critical region in Xp21.

artículo científico publicado en 1995

A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors

artículo científico publicado en 2005

A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

artículo científico publicado en 2014

Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway

artículo científico publicado en 2013

Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy

scientific article published on 18 December 2018

Autologous versus allogeneic cell-based vaccines?

artículo científico

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy

scientific article published on 06 February 2020

Cholesterol metabolites and tumor microenvironment: the road towards clinical translation.

artículo científico publicado en 2015

Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes

artículo científico publicado en 2012

Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling

artículo científico publicado en 2013

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

artículo científico publicado en 2000

Detection and Functional Analysis of Tumor-Derived LXR Ligands

artículo científico publicado en 2016

Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion

artículo científico publicado en 2005

Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.

artículo científico publicado en 2011

Endosomal proteases influence the repertoire of MAGE-A3 epitopes recognized in vivo by CD4+ T cells

artículo científico publicado en 2008

Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.

artículo científico publicado en 1995

Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.

artículo científico publicado en 2006

IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes

artículo científico publicado en 2008

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

artículo científico publicado en 2012

Identification of novel sense and antisense transcription at the TRPM2 locus in cancer

artículo científico publicado en 2008

Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis

artículo científico publicado en 2013

LXR-dependent and -independent effects of oxysterols on immunity and tumor growth

artículo científico publicado en 2014

Metabolism, LXR/LXR ligands, and tumor immune escape.

scientific article published on 19 July 2011

Molecular dissection of the migrating posterior lateral line primordium during early development in zebrafish.

artículo científico publicado en 2010

New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient

artículo científico publicado en 2015

Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer

artículo científico publicado en 2012

Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validation

artículo científico publicado en 2014

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols

artículo científico publicado en 2013

Peptide-based vaccines for cancer therapy

artículo científico publicado en 2014

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

artículo científico publicado en 2008

Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies.

artículo científico publicado en 2004

Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo

artículo científico publicado en 2008

Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.

artículo científico publicado en 2010

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.

artículo científico publicado en 2009

T Cells as Antigen Carriers for Anti-tumor Vaccination

artículo científico publicado en 2016

Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.

artículo científico publicado en 2013

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.

artículo científico publicado en 2008

The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.

artículo científico publicado en 2016

The hidden (and lazy) TCR

artículo científico publicado en 2009

The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

artículo científico publicado en 2013

The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens

artículo científico publicado en 2005

The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells

artículo científico publicado en 2006

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

artículo científico publicado en 2009

Universal and Stemness-Related Tumor Antigens: Potential Use in Cancer Immunotherapy

artículo científico publicado en 2007

Lista de obras de Vincenzo Russo

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes

A dual role for genetically modified lymphocytes in cancer immunotherapy.

A family of rapidly evolving genes from the sex reversal critical region in Xp21.

A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors

A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway

Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy

Autologous versus allogeneic cell-based vaccines?

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy

Cholesterol metabolites and tumor microenvironment: the road towards clinical translation.

Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes

Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

Detection and Functional Analysis of Tumor-Derived LXR Ligands

Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion

Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.

Endosomal proteases influence the repertoire of MAGE-A3 epitopes recognized in vivo by CD4+ T cells

Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.

Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.

IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

Identification of novel sense and antisense transcription at the TRPM2 locus in cancer

Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis

LXR-dependent and -independent effects of oxysterols on immunity and tumor growth

Metabolism, LXR/LXR ligands, and tumor immune escape.

Molecular dissection of the migrating posterior lateral line primordium during early development in zebrafish.

New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient

Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer

Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validation

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols

Peptide-based vaccines for cancer therapy

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies.

Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo

Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.

T Cells as Antigen Carriers for Anti-tumor Vaccination

Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.

The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.

The hidden (and lazy) TCR

The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens

The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

Universal and Stemness-Related Tumor Antigens: Potential Use in Cancer Immunotherapy